Used in Suzuki-Miyaura cross-coupling reactions as a boronic acid reagent for constructing biaryl compounds in pharmaceutical synthesis. Its fluorinated aromatic structure enhances reactivity and selectivity in coupling processes. Commonly employed in the development of active pharmaceutical ingredients (APIs) where fluorine substitution improves metabolic stability and bioavailability. Also utilized in medicinal chemistry research for generating fluorinated analogs of lead compounds to optimize drug properties. Stable under standard handling conditions, making it suitable for automated synthesis platforms.